Novel GABA- and Ornithine Aminotransferase Inactivators and Potential New Treatments for Epilepsy, Addiction, Neuropathic Pain, and Hepatocellular Carcinoma
Abstract: An imbalance in the levels of the inhibitory neurotransmitter g-aminobutyric acid (GABA) and the excitatory neurotransmitter L-glutamate can lead to convulsions. Inhibition of g-aminobutyric acid aminotransferase (GABA-AT), the enzyme responsible for the degradation of GABA, increases brain GABA levels, which has been shown to produce an anticonvulsant effect. Reduced brain GABA concentration also is […]